S100A1: a multifaceted therapeutic target in cardiovascular disease.

Journal of Cardiovascular Translational Research
David RohdeP Most

Abstract

Cardiovascular disease is the leading cause of death worldwide, showing a dramatically growing prevalence. It is still associated with a poor clinical prognosis, indicating insufficient long-term treatment success of currently available therapeutic strategies. Investigations of the pathomechanisms underlying cardiovascular disorders uncovered the Ca(2+) binding protein S100A1 as a critical regulator of both cardiac performance and vascular biology. In cardiomyocytes, S100A1 was found to interact with both the sarcoplasmic reticulum ATPase (SERCA2a) and the ryanodine receptor 2 (RyR2), resulting in substantially improved Ca(2+) handling and contractile performance. Additionally, S100A1 has been described to target the cardiac sarcomere and mitochondria, leading to reduced pre-contractile passive tension as well as enhanced oxidative energy generation. In endothelial cells, molecular analyses revealed a stimulatory effect of S100A1 on endothelial NO production by increasing endothelial nitric oxide synthase activity. Emphasizing the pathophysiological relevance of S100A1, myocardial infarction in S100A1 knockout mice resulted in accelerated transition towards heart failure and excessive mortality in comparison with wild-type cont...Continue Reading

References

Aug 1, 1991·Brain Research Bulletin·D B ZimmerW E Zimmer
Oct 17, 1985·Biochimica Et Biophysica Acta·K Kato, S Kimura
Jun 9, 1965·Biochemical and Biophysical Research Communications·B W Moore
May 1, 1994·Neuroscience·M A MariggióG Fanó
Apr 18, 1996·Nature·J HeierhorstB E Kemp
Oct 11, 1996·Biochimica Et Biophysica Acta·A RemppisC W Heizmann
Mar 7, 1998·FEBS Letters·A A PolyakovN B Gusev
Aug 5, 2000·Biochemical and Biophysical Research Communications·R KiewitzC W Heizmann
Dec 8, 2000·Biochimica Et Biophysica Acta·R KiewitzC W Heizmann
May 30, 2001·European Journal of Heart Failure·S StewartJ J McMurray
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·P MostA Remppis
Mar 23, 2002·Molecular and Cellular Biology·Xiao-Jun DuJörg Heierhorst
May 7, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Claus W HeizmannBeat W Schäfer
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·James N TsoporisThomas G Parker
Oct 24, 2002·Journal of Molecular and Cellular Cardiology·Robert S Balaban
Mar 20, 2003·Microscopy Research and Technique·Rosario Donato
Mar 20, 2003·Microscopy Research and Technique·Danna B ZimmerDavid J Weber
Apr 18, 2003·Lancet·Dirk FoellJohannes Roth
May 15, 2003·Molecular Membrane Biology·J Alfonso LeyvaL Mario Amzel
Jun 14, 2003·Biochemical and Biophysical Research Communications·Roland KiewitzClaus W Heizmann
Nov 15, 2003·Circulation Research·Martin J LohseThomas Eschenhagen
Apr 14, 2004·The Journal of Gene Medicine·Andrew RemppisHugo A Katus
Sep 1, 2004·Biochemical and Biophysical Research Communications·Ingo MarenholzGünter Fritz
Dec 4, 2004·The Journal of Clinical Investigation·Patrick MostWalter J Koch
Dec 14, 2004·Biochimica Et Biophysica Acta·Liliya ZhukovaAleksandra Wyslouch-Cieszynska
Mar 15, 2005·The Journal of Clinical Investigation·Joshua M Hare, Jonathan S Stamler
May 12, 2005·The FEBS Journal·Grazyna GochAndrzej Bierzyñski
Jun 1, 2005·Life Sciences·Guilherme S MazziniLuis V C Portela

❮ Previous
Next ❯

Citations

Dec 7, 2011·Current Heart Failure Reports·Razmig Garo Kratlian, Roger J Hajjar
Feb 18, 2012·Gene Therapy·J Ritterhoff, P Most
Sep 20, 2012·The Journal of Biological Chemistry·Martina Lenarčič ŽivkovićAleksandra Wysłouch-Cieszyńska
Aug 28, 2012·International Journal of General Medicine·Mehrnoush ToufanMajid Khalili
Jul 28, 2012·Current Molecular Medicine·R DonatoC L Geczy
Dec 25, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Tong Tang, H Kirk Hammond
Mar 13, 2012·Heart Failure Clinics·Anne L Taylor
Mar 10, 2016·Biophysical Journal·Caitlin E Scott, Peter M Kekenes-Huskey
Jul 25, 2015·Stem Cell Research & Therapy·Carolina Gálvez-MontónAntoni Bayes-Genis
Apr 17, 2015·The Journal of Pharmacy and Pharmacology·Jiangkun YuLeiming Wu
Sep 1, 2012·Biochemical Pharmacology·Shaina R EckhouseFrancis G Spinale
May 23, 2014·The American Journal of Cardiology·Keith Copelin FerdinandChristopher Leggett
Sep 30, 2016·Basic Research in Cardiology·Friederike Cuello, Kristina Lorenz
May 26, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julia RitterhoffPatrick Most
Dec 8, 2016·Journal of Cellular Physiology·José Diaz-Romero, Dobrila Nesic
Jan 24, 2015·Nature Reviews. Cancer·Anne R BresnickDanna B Zimmer
May 1, 2010·Expert Review of Clinical Pharmacology·Ivan BogeskiChristine Peinelt
Aug 8, 2013·Journal of Cardiovascular Pharmacology·Armen YerevanianRoger J Hajjar
Oct 28, 2019·International Journal of Molecular Sciences·Vera PaarLukas J Motloch
Jul 14, 2020·Frontiers in Molecular Biosciences·Bin Sun, Peter M Kekenes-Huskey
Jul 30, 2020·Cancers·Chantal AllgöwerJohannes Lemke
Jul 23, 2020·Biophysics Reviews·Amanda L DennissNicole A Beard
Oct 25, 2020·Journal of Basic and Clinical Physiology and Pharmacology·Keneth Iceland KasoziMiriela Betancourt Valladares
Dec 4, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xuan XiaoChi Zhang
Aug 10, 2021·Frontiers in Pharmacology·Wenkai YangJianguo Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
confocal microscopy
co-immunoprecipitation

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.